Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: We previously demonstrated that positive allosteric modulators (PAMs) of metabotropic glutamate subtype 2 (mGlu ) receptors have potential synergistic interactions with the antiseizure drug levetiracetam (LEV). The present study utilizes isobolographic analysis to evaluate the combined administration of JNJ-46356479, a selective and potent mGlu PAM, with LEV as well as sodium valproate (VPA) and lamotrigine (LTG).
Methods: The anticonvulsant efficacy of JNJ-46356479 was evaluated in the 6-Hz model of psychomotor seizures in mice. JNJ-46356479 was administered in combination with LEV using 3 fixed dose-ratio treatment groups in the mouse 6-Hz (44-mA) seizure test. The combination of JNJ-46356479 with LEV was also evaluated in the mouse corneal kindling model. The potential interactions of JNJ-46356479 with the antiseizure drugs VPA and LTG were also evaluated using fixed dose-ratio combinations. Plasma levels were obtained for analysis of potential pharmacokinetic interactions for each combination studied in the mouse 6-Hz model.
Results: JNJ-46356479 was active in the 6-Hz model at both 32-mA and 44-mA stimulus intensities (median effective dose = 2.8 and 10.2 mg/kg, respectively). Using 1:1, 1:3, and 3:1 fixed dose-ratio combinations (LEV:JNJ-46356479), coadministration was significantly more potent than predicted for additive effects, and plasma levels suggest this synergism was not due to pharmacokinetic interactions. Studies in kindled mice further demonstrate the positive pharmacodynamic interaction of LEV with JNJ-46356479. Using 1:1 dose-ratio combinations of JNJ-46356479 with either VPA or LTG, there were no significant differences observed for coadministration.
Significance: These studies demonstrate a synergistic interaction of JNJ-46356479 with LEV, whereas no such effect occurred for JNJ-46356479 with either VPA or LTG. The synergy seems therefore to be specific to LEV, and the combination LEV/mGlu PAM has the potential to result in a rational polypharmacy approach to treat patients with refractory epilepsy, once it has been confirmed in clinical studies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/epi.14005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Triptolide Inhibits Epileptic Seizures by Rescuing the Neuroinflammation-Related GABAergic Dysfunction in Mice.
CNS Neurosci Ther
August 2025
Research Institute of Chinese Medical Clinical Foundation and Immunology & TCM Science and Research Center, Wenzhou TCM Hospital of Zhejiang Chinese Medical University, College of Basic Medical Science, Zhejiang Chinese Medical University, Zhejiang, China.
Objective: This study aims to evaluate the antiepileptic effect of triptolide (TPL), a strong anti-inflammatory and immunosuppressive diterpenoid compound from a Chinese herb medicine Tripterygium wilfordii Hook F (TWHF).
Methods: The pentylenetetrazol (PTZ)-induced seizure model, maximal electroshock seizure (MES) model, corneal (6 Hz) kindling model, and kainic acid (KA) mouse model were used to assess the antiepileptic effect of TPL. EEG recording and behavioral tests were used to evaluate the disease-modifying effects of TPL in epileptic conditions.
IDOR-1104-0086, a novel Kv7 channel activator with antiseizure effects in rodents.
Neuropharmacology
August 2025
Idorsia Pharmaceuticals Ltd, Department of Drug Discovery, CNS-Pharmacology Division, Allschwil, Switzerland.
A neuronal, phenotypic in vitro screen at Idorsia identified IDOR-1104-0086 as a small molecule with antiseizure effects and drug-like properties. Target deconvolution revealed its mechanism as activating voltage-gated potassium (Kv7) channels, which stabilize the resting membrane potential and modulate cellular excitability. In the current study, we further investigated IDOR-1104-0086's potency and selectivity profile on Kv7.
View Article and Find Full Text PDFPAC-FOS: A novel translational concordance framework identifies preclinical seizure models with highest predictive validity for clinical focal onset seizures.
Epilepsia
August 2025
Praxis Precision Medicines, Boston, Massachusetts, USA.
Objective: Central to the development of novel antiseizure medications (ASMs) is testing of antiseizure activity in preclinical models. Although various well-established models exist, their predictive validity across the spectrum of clinical epilepsies has been less clear. We sought to establish the translational concordance of commonly used preclinical models to define models with the highest predictive clinical validity for focal onset seizures (FOS).
View Article and Find Full Text PDFDevelopment and application of vibrating dynamic culture system for mouse oocytes and embryos.
Front Vet Sci
July 2025
Sport Biomechanics Center, Institute of Artificial Intelligence in Sports, Capital University of Physical Education and Sports, Beijing, China.
Background: Mammalian oocytes fertilization and early embryos development primarily take place in the fallopian tube, which not only provides nutrients but also offers a suitable mechanical environment. The current culture system for oocytes and embryos in assisted reproductive technology is static, leading to weak developmental potential and an implantation rate of only 30%-40%. It is speculated that the low developmental potential may be due to the significant difference between the static culture method and the dynamic mechanical environment of the embryos.
View Article and Find Full Text PDFSeventy % of mammals copulate using repeated pelvic thrusting, while the transfer of sperm requires just a single intromission. Why did thrusting evolve to be the dominant form of sexual intercourse? In this study, we investigate how the rate of sexual pelvic thrusting changes with body size. By analyzing films of copulating mammals, from mice Mus musculus to elephants Elephantidae, we find that bigger animals thrust slower.
View Article and Find Full Text PDF